EA201991976A1 - Метаболически оптимизированная клеточная культура - Google Patents

Метаболически оптимизированная клеточная культура

Info

Publication number
EA201991976A1
EA201991976A1 EA201991976A EA201991976A EA201991976A1 EA 201991976 A1 EA201991976 A1 EA 201991976A1 EA 201991976 A EA201991976 A EA 201991976A EA 201991976 A EA201991976 A EA 201991976A EA 201991976 A1 EA201991976 A1 EA 201991976A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cell culture
proteins
optimized cell
present
polypeptides
Prior art date
Application number
EA201991976A
Other languages
English (en)
Russian (ru)
Inventor
Шон Лоуренс
Энн Ким
Эми Джонсон
Original Assignee
Регенерон Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52813657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201991976(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Регенерон Фармасьютикалз, Инк. filed Critical Регенерон Фармасьютикалз, Инк.
Publication of EA201991976A1 publication Critical patent/EA201991976A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/60Buffer, e.g. pH regulation, osmotic pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
EA201991976A 2013-10-11 2014-10-10 Метаболически оптимизированная клеточная культура EA201991976A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361889815P 2013-10-11 2013-10-11

Publications (1)

Publication Number Publication Date
EA201991976A1 true EA201991976A1 (ru) 2020-04-02

Family

ID=52813657

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201690600A EA033783B1 (ru) 2013-10-11 2014-10-10 Метаболически оптимизированная клеточная культура
EA201991976A EA201991976A1 (ru) 2013-10-11 2014-10-10 Метаболически оптимизированная клеточная культура

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201690600A EA033783B1 (ru) 2013-10-11 2014-10-10 Метаболически оптимизированная клеточная культура

Country Status (17)

Country Link
US (2) US20160244725A1 (cg-RX-API-DMAC7.html)
EP (3) EP3055409B1 (cg-RX-API-DMAC7.html)
JP (3) JP6663854B2 (cg-RX-API-DMAC7.html)
KR (4) KR102243980B1 (cg-RX-API-DMAC7.html)
CN (2) CN114717196A (cg-RX-API-DMAC7.html)
AU (2) AU2014331776B2 (cg-RX-API-DMAC7.html)
CA (1) CA2926049C (cg-RX-API-DMAC7.html)
DK (2) DK3351620T3 (cg-RX-API-DMAC7.html)
EA (2) EA033783B1 (cg-RX-API-DMAC7.html)
ES (2) ES2678945T3 (cg-RX-API-DMAC7.html)
HU (2) HUE051049T2 (cg-RX-API-DMAC7.html)
IL (2) IL244511A0 (cg-RX-API-DMAC7.html)
MX (2) MX376623B (cg-RX-API-DMAC7.html)
PL (2) PL3055409T3 (cg-RX-API-DMAC7.html)
SG (2) SG11201601681QA (cg-RX-API-DMAC7.html)
WO (1) WO2015054554A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201601550B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014331776B2 (en) 2013-10-11 2020-10-22 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
US20160244726A1 (en) * 2013-10-11 2016-08-25 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
JP7260018B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260020B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260011B2 (ja) * 2017-03-31 2023-04-18 株式会社三洋物産 遊技機
JP7260012B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7272480B2 (ja) * 2017-04-27 2023-05-12 株式会社三洋物産 遊技機
JP7310952B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7310945B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7310947B2 (ja) * 2017-04-27 2023-07-19 株式会社三洋物産 遊技機
JP7260013B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260021B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
JP7260009B2 (ja) * 2017-04-27 2023-04-18 株式会社三洋物産 遊技機
WO2019071076A1 (en) 2017-10-06 2019-04-11 Lonza Ltd. AUTOMATED CONTROL OF CELL CULTURE BY SPECTROSCOPY RAMAN
CA3075679A1 (en) 2017-10-16 2019-04-25 Regeneron Pharmaceuticals, Inc. Perfusion bioreactor and related methods of use
EP3717656B1 (en) * 2017-11-30 2024-03-13 F. Hoffmann-La Roche AG Process for culturing mammalian cells
AR115318A1 (es) * 2018-03-29 2020-12-23 Genentech Inc Modulación de la actividad lactogénica en células de mamífero
GB201810772D0 (en) 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
JP7231355B2 (ja) * 2018-08-22 2023-03-01 日機装株式会社 細胞培養方法および細胞培養装置
JP2021535739A (ja) 2018-08-27 2021-12-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 下流精製でのラマン分光法の使用
JP2020151560A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
JP2020151559A (ja) * 2020-06-24 2020-09-24 株式会社三洋物産 遊技機
EP3985097A1 (en) * 2020-10-14 2022-04-20 Sartorius Stedim Biotech GmbH A method and system for configuring and/or setup of a downstream process for processing a biomass

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
KR970029803A (ko) 1995-11-03 1997-06-26 김광호 반도체 메모리장치의 프리차지 회로
US6165741A (en) 1997-05-30 2000-12-26 The Trustees Of The University Of Pennsylvania Method for rapid detection of bacterial growth in cultures
US5972650A (en) 1997-06-26 1999-10-26 Brigham And Women's Hospital Tetracycline repressor regulated mammalian cell transcription and viral replication switch
CA2434802C (en) 2001-01-16 2013-05-28 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
CA2417689C (en) 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Improved methods for growing mammalian cells in vitro
US7039770B1 (en) 2002-03-05 2006-05-02 Juniper Networks, Inc. Low latency request dispatcher
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
DK1623019T4 (en) 2003-05-15 2017-03-27 Wyeth Llc LIMITED GLUCOSE SUPPLY TO ANIMAL CELL CULTURE
US7531327B2 (en) * 2004-07-23 2009-05-12 Immunomedics, Inc. Methods and compositions for increasing longevity and protein yield from a cell culture
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
TWI364458B (en) * 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
EP1943333A2 (en) * 2005-11-02 2008-07-16 Wyeth a Corporation of the State of Delaware Methods for adapting mammalian cells
EP1973576B1 (en) 2005-11-28 2019-05-15 Genmab A/S Recombinant monovalent antibodies and methods for production thereof
US7575890B2 (en) 2006-01-18 2009-08-18 Oxygen Enterprises, Ltd. Method for rapid detection and evaluation of cultured cell growth
MX2009004519A (es) 2006-11-03 2009-05-12 Wyeth Corp Sustancias que inhiben la glucolisis en un cultivo de celulas.
EP2150617B1 (en) 2007-06-04 2014-10-22 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
ES2657055T3 (es) 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
MX2010013728A (es) * 2008-06-13 2011-01-14 Centocor Ortho Biotech Inc Metodos para lograr una alta densidad de celulas viables en cultivos de celulas de mamiferos.
US8470552B2 (en) * 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
EP2563904B1 (en) * 2010-04-26 2015-01-21 Novartis AG Improved cell culture medium
HUE030820T2 (en) * 2010-05-28 2017-06-28 Hoffmann La Roche Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
WO2014109858A1 (en) * 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
AU2014331776B2 (en) 2013-10-11 2020-10-22 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture

Also Published As

Publication number Publication date
US20160244725A1 (en) 2016-08-25
MX2016004564A (es) 2016-07-12
KR102610425B1 (ko) 2023-12-06
IL244511A0 (en) 2016-04-21
CN105637085A (zh) 2016-06-01
ES2833471T3 (es) 2021-06-15
EA033783B1 (ru) 2019-11-25
MX2020011334A (es) 2021-07-30
ES2678945T3 (es) 2018-08-21
MX384960B (es) 2025-03-14
HK1223122A1 (en) 2017-07-21
EP3351620A1 (en) 2018-07-25
HUE039551T2 (hu) 2019-01-28
KR102358807B1 (ko) 2022-02-08
ZA201601550B (en) 2023-05-31
DK3351620T3 (da) 2020-10-26
SG11201601681QA (en) 2016-04-28
KR20230038324A (ko) 2023-03-17
HUE051049T2 (hu) 2021-01-28
EP3055409A1 (en) 2016-08-17
CA2926049C (en) 2023-09-05
AU2014331776A1 (en) 2016-03-24
HK1253275A1 (en) 2019-06-14
KR20220020415A (ko) 2022-02-18
PL3351620T3 (pl) 2021-03-08
IL262833A (en) 2018-12-31
JP6663854B2 (ja) 2020-03-13
US20210087535A1 (en) 2021-03-25
MX376623B (es) 2025-03-07
JP2016532457A (ja) 2016-10-20
PL3055409T3 (pl) 2018-10-31
CN114717196A (zh) 2022-07-08
CA2926049A1 (en) 2015-04-16
EA201690600A1 (ru) 2016-09-30
EP3055409B1 (en) 2018-04-25
KR20160062032A (ko) 2016-06-01
AU2021200193B2 (en) 2023-08-24
KR102243980B1 (ko) 2021-04-26
WO2015054554A1 (en) 2015-04-16
JP2022009453A (ja) 2022-01-14
DK3055409T3 (en) 2018-07-30
AU2014331776B2 (en) 2020-10-22
SG10201800772TA (en) 2018-03-28
AU2021200193A1 (en) 2021-03-18
JP7377243B2 (ja) 2023-11-09
EP3055409A4 (en) 2016-09-28
JP2020072760A (ja) 2020-05-14
EP3351620B1 (en) 2020-09-02
EP3812453A1 (en) 2021-04-28
KR102510238B1 (ko) 2023-03-16
KR20210046835A (ko) 2021-04-28
JP6967620B2 (ja) 2021-11-17

Similar Documents

Publication Publication Date Title
EA201991976A1 (ru) Метаболически оптимизированная клеточная культура
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
SG10201809152QA (en) Recombinant host cell for expressing proteins of interest
SG10201809146QA (en) Recombinant host cell engineered to overexpress helper proteins
EA201692498A1 (ru) Способы сбора культур клеток млекопитающих
MY181513A (en) Cell culture compositions and methods for polypeptide production
PH12015501837A1 (en) Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recominbinant proteins
WO2011091350A3 (en) Methods & compositions for improving protein production
EA201490631A1 (ru) Способы культивирования клеток млекопитающих для получения белка
WO2012135805A3 (en) Delivery and formulation of engineered nucleic acids
EA201691297A1 (ru) Среда для культивирования клеток
EA201491144A1 (ru) Способ флокуляции
EA202091407A1 (ru) Состав бессывороточной среды для культивирования клеток и способы его применения
WO2013009648A3 (en) Cell culture process
EA201590550A1 (ru) Композиции и способы получения гликопротеинов
MX2015005822A (es) Procesamiento discontinuo de alimentacion por lotes con el uso de biorreactores alternantes.
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
MX2015007361A (es) Produccion mediada por la proteina portadora de acilo de los derivados de acidos grasos.
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
PH12016502406A1 (en) Cell culture process for producing a protein
IN2014CN03077A (cg-RX-API-DMAC7.html)
MY180183A (en) Methods and compositions for preventing norleucine misincorporation into proteins
EA201992828A1 (ru) Способы культивирования клеток
MX2015010887A (es) Formulaciones y metodos para aumentar la produccion de proteinas recombinantes.
EA201591723A1 (ru) Применение термофильных нуклеаз для разрушения нуклеиновых кислот